• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

基于 Epstein-Barr 病毒的鼻咽癌(NPC)风险预测评分在台湾 NPC 多灶性家族成员中升高。

Epstein-Barr Virus-Based Nasopharyngeal Carcinoma (NPC) Risk Prediction Scores Are Elevated in NPC Multiplex Family Members in Taiwan.

机构信息

Institute of Clinical Medicine, National Yang-Ming University, Taipei, Taiwan.

Cancer Epidemiology Program, Division of Population Science, H. Lee Moffitt Cancer Center and Research Institute, Tampa, Florida, USA.

出版信息

J Infect Dis. 2021 Feb 13;223(3):441-444. doi: 10.1093/infdis/jiaa385.

DOI:10.1093/infdis/jiaa385
PMID:32614957
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC7982447/
Abstract

Nasopharyngeal carcinoma (NPC) is caused by Epstein-Barr virus (EBV) and is more likely to occur in susceptible families. Whether genetic susceptibility operates through altered EBV control is incompletely understood. We used a NPC risk prediction model based on 14 EBV markers to compare risk score distribution in unaffected members from multiplex families with that in population-based controls. Despite the absence of NPC at the time of antibody measurement, we observed an upward shift in risk score among multiplex family members compared to the general population, consistent with the possibility that genetic factors affect NPC risk through alterations in EBV control.

摘要

鼻咽癌(NPC)是由 Epstein-Barr 病毒(EBV)引起的,更容易发生在易感家族中。遗传易感性是否通过改变 EBV 的控制来发挥作用尚不完全清楚。我们使用了一个基于 14 个 EBV 标志物的 NPC 风险预测模型,比较了多基因家族中未受影响成员与基于人群对照者的风险评分分布。尽管在抗体测量时没有 NPC,但我们观察到多基因家族成员的风险评分与普通人群相比有所上升,这表明遗传因素可能通过改变 EBV 的控制来影响 NPC 的风险。

相似文献

1
Epstein-Barr Virus-Based Nasopharyngeal Carcinoma (NPC) Risk Prediction Scores Are Elevated in NPC Multiplex Family Members in Taiwan.基于 Epstein-Barr 病毒的鼻咽癌(NPC)风险预测评分在台湾 NPC 多灶性家族成员中升高。
J Infect Dis. 2021 Feb 13;223(3):441-444. doi: 10.1093/infdis/jiaa385.
2
Kinetics of EBV antibody-based NPC risk scores in Taiwan NPC multiplex families.基于 EBV 抗体的 NPC 风险评分在台湾 NPC 家系中的动力学研究。
Int J Cancer. 2024 Oct 15;155(8):1400-1408. doi: 10.1002/ijc.35037. Epub 2024 Jun 1.
3
Cigarette smoking increases the risk of nasopharyngeal carcinoma through the elevated level of IgA antibody against Epstein-Barr virus capsid antigen: A mediation analysis.吸烟通过提高针对 Epstein-Barr 病毒衣壳抗原的 IgA 抗体水平增加鼻咽癌风险:一项中介分析。
Cancer Med. 2020 Mar;9(5):1867-1876. doi: 10.1002/cam4.2832. Epub 2020 Jan 10.
4
Identification of a Novel, EBV-Based Antibody Risk Stratification Signature for Early Detection of Nasopharyngeal Carcinoma in Taiwan.鉴定新型 EBV 相关抗体风险分层标志物,用于早期检测台湾地区的鼻咽癌。
Clin Cancer Res. 2018 Mar 15;24(6):1305-1314. doi: 10.1158/1078-0432.CCR-17-1929. Epub 2018 Jan 4.
5
Elevated Epstein-Barr virus seroreactivity among unaffected members of families with nasopharyngeal carcinoma.鼻咽癌患者家族中未患病成员的 Epstein-Barr 病毒血清反应升高。
J Med Virol. 2011 Oct;83(10):1792-8. doi: 10.1002/jmv.22121.
6
High Levels of Antibody that Neutralize B-cell Infection of Epstein-Barr Virus and that Bind EBV gp350 Are Associated with a Lower Risk of Nasopharyngeal Carcinoma.高水平的可中和爱泼斯坦-巴尔病毒B细胞感染以及可结合EBV gp350的抗体与鼻咽癌风险降低相关。
Clin Cancer Res. 2016 Jul 15;22(14):3451-7. doi: 10.1158/1078-0432.CCR-15-2299. Epub 2016 Feb 26.
7
Distribution of Epstein-Barr viral load in serum of individuals from nasopharyngeal carcinoma high-risk families in Taiwan.台湾鼻咽癌高危家族个体血清中爱泼斯坦-巴尔病毒载量的分布
Int J Cancer. 2006 Feb 1;118(3):780-4. doi: 10.1002/ijc.21396.
8
Natural Variations in BRLF1 Promoter Contribute to the Elevated Reactivation Level of Epstein-Barr Virus in Endemic Areas of Nasopharyngeal Carcinoma.BRLF1 启动子中的自然变异导致鼻咽癌高发地区 EBV 再激活水平升高。
EBioMedicine. 2018 Nov;37:101-109. doi: 10.1016/j.ebiom.2018.10.065. Epub 2018 Nov 9.
9
Comparison of Epstein-Barr Virus Serological Tools for the Screening and Risk Assessment of Nasopharyngeal Carcinoma: a Large Population-based Study.用于鼻咽癌筛查和风险评估的 Epstein-Barr 病毒血清学工具的比较:一项大型基于人群的研究。
Pathol Oncol Res. 2020 Oct;26(4):2185-2190. doi: 10.1007/s12253-020-00808-0. Epub 2020 Mar 28.
10
Epstein-Barr virus seroreactivity among unaffected individuals within high-risk nasopharyngeal carcinoma families in Taiwan.台湾高危鼻咽癌家族中未受影响个体的爱泼斯坦-巴尔病毒血清反应性
Int J Cancer. 2004 Aug 10;111(1):117-23. doi: 10.1002/ijc.20222.

引用本文的文献

1
Diagnostic value of BNLF2b antibody, dual-antibody testing and Epstein-Barr virus DNA in nasopharyngeal carcinoma: a prospective cohort study in Hunan Province, China.BNLF2b抗体、双抗体检测及爱泼斯坦-巴尔病毒DNA在鼻咽癌中的诊断价值:一项在中国湖南省开展的前瞻性队列研究
BMJ Open. 2025 May 21;15(5):e100538. doi: 10.1136/bmjopen-2025-100538.
2
Prospective evaluation of the relevance of Epstein-Barr virus antibodies for early detection of nasopharyngeal carcinoma in Chinese adults.前瞻性评估 Epstein-Barr 病毒抗体在中国人中早期检测鼻咽癌的相关性。
Int J Epidemiol. 2024 Jun 12;53(4). doi: 10.1093/ije/dyae098.
3
Kinetics of EBV antibody-based NPC risk scores in Taiwan NPC multiplex families.基于 EBV 抗体的 NPC 风险评分在台湾 NPC 家系中的动力学研究。
Int J Cancer. 2024 Oct 15;155(8):1400-1408. doi: 10.1002/ijc.35037. Epub 2024 Jun 1.
4
Characterization of the humoral immune response to the EBV proteome in extranodal NK/T-cell lymphoma.描述结外 NK/T 细胞淋巴瘤中针对 EBV 蛋白质组的体液免疫反应。
Sci Rep. 2021 Dec 8;11(1):23664. doi: 10.1038/s41598-021-02788-w.
5
SSTR2 in Nasopharyngeal Carcinoma: Relationship with Latent EBV Infection and Potential as a Therapeutic Target.鼻咽癌中的生长抑素受体2:与潜伏性EB病毒感染的关系及作为治疗靶点的潜力
Cancers (Basel). 2021 Sep 30;13(19):4944. doi: 10.3390/cancers13194944.

本文引用的文献

1
Incidence and mortality of nasopharyngeal carcinoma: interim analysis of a cluster randomized controlled screening trial (PRO-NPC-001) in southern China.鼻咽癌的发病率和死亡率:中国南方一项集群随机对照筛查试验(PRO-NPC-001)的中期分析。
Ann Oncol. 2019 Oct 1;30(10):1630-1637. doi: 10.1093/annonc/mdz231.
2
Whole-Exome Sequencing of Nasopharyngeal Carcinoma Families Reveals Novel Variants Potentially Involved in Nasopharyngeal Carcinoma.全外显子组测序鼻咽癌家系揭示了潜在参与鼻咽癌的新变异体。
Sci Rep. 2019 Jul 9;9(1):9916. doi: 10.1038/s41598-019-46137-4.
3
Elevated antibodies against Epstein-Barr virus among individuals predicted to carry nasopharyngeal carcinoma susceptibility variants.在预测携带鼻咽癌易感性变异体的个体中,针对 Epstein-Barr 病毒的抗体升高。
J Gen Virol. 2018 Sep;99(9):1268-1273. doi: 10.1099/jgv.0.001115. Epub 2018 Jul 5.
4
Identification of a Novel, EBV-Based Antibody Risk Stratification Signature for Early Detection of Nasopharyngeal Carcinoma in Taiwan.鉴定新型 EBV 相关抗体风险分层标志物,用于早期检测台湾地区的鼻咽癌。
Clin Cancer Res. 2018 Mar 15;24(6):1305-1314. doi: 10.1158/1078-0432.CCR-17-1929. Epub 2018 Jan 4.
5
A genome-wide integrative genomic study localizes genetic factors influencing antibodies against Epstein-Barr virus nuclear antigen 1 (EBNA-1).一项全基因组整合基因组研究定位了影响针对 Epstein-Barr 病毒核抗原 1(EBNA-1)抗体的遗传因素。
PLoS Genet. 2013;9(1):e1003147. doi: 10.1371/journal.pgen.1003147. Epub 2013 Jan 10.
6
Two Epstein-Barr virus-related serologic antibody tests in nasopharyngeal carcinoma screening: results from the initial phase of a cluster randomized controlled trial in Southern China.两种与 Epstein-Barr 病毒相关的血清学抗体检测在鼻咽癌筛查中的应用:来自中国南方一项聚类随机对照试验初始阶段的结果。
Am J Epidemiol. 2013 Feb 1;177(3):242-50. doi: 10.1093/aje/kws404. Epub 2012 Dec 19.
7
Invited commentary: Epstein-Barr virus-based screening for the early detection of nasopharyngeal carcinoma: a new frontier.特邀评论:基于 Epstein-Barr 病毒的鼻咽癌早期检测筛查:新前沿。
Am J Epidemiol. 2013 Feb 1;177(3):251-3. doi: 10.1093/aje/kws403. Epub 2012 Dec 19.
8
Genetic predisposition factors and nasopharyngeal carcinoma risk: a review of epidemiological association studies, 2000-2011: Rosetta Stone for NPC: genetics, viral infection, and other environmental factors.遗传易感性因素与鼻咽癌风险:2000-2011 年流行病学关联研究综述:鼻咽癌的罗塞塔石:遗传学、病毒感染和其他环境因素。
Semin Cancer Biol. 2012 Apr;22(2):107-16. doi: 10.1016/j.semcancer.2012.01.007. Epub 2012 Jan 25.
9
Prognostic utility of anti-EBV antibody testing for defining NPC risk among individuals from high-risk NPC families.抗 EBV 抗体检测对高危 NPC 家族个体 NPC 风险的预测价值。
Clin Cancer Res. 2011 Apr 1;17(7):1906-14. doi: 10.1158/1078-0432.CCR-10-1681. Epub 2011 Mar 29.
10
Evaluation of nonviral risk factors for nasopharyngeal carcinoma in a high-risk population of Southern China.中国南方高危人群中鼻咽癌非病毒危险因素的评估。
Int J Cancer. 2009 Jun 15;124(12):2942-7. doi: 10.1002/ijc.24293.